SPEAKER: David Ohlssen (Novartis Pharmaceuticals Corporation)
Guidance on the implementation and reporting of a drug safety Bayesian network meta-analysis
Authors: Karen L. Price, H. Amy Xia, Hwanhee Hong, Jouni Kerman, Haoda Fu, George Quartey, Cory R. Heilmann, Haijun Ma and Bradley P. Carlin;
Pharmaceutical Statistics, Volume 13, Issue 1, Pages 55–70, January/February 2014 Abstract | Paper+ | Slides
SPEAKER: Christine Fletcher (Amgen Ltd)
Subgroup analyses in cost-effectiveness analyses to support health technology assessments
Authors: Christy Chuang-Stein, Marie-Ange Paget, Carol Reid and Neil Hawkins;
Pharmaceutical Statistics, Volume 13, Issue 4, Pages 265-274, July/August 2014 Abstract | Paper+ | Slides
+Papers available to view from 18th November 2014 to 16th December 2014
For a flier advertising the event, please click here.
Upcoming Events
PSI EIWG Webinar: PIONEERing estimands in Clinical Research (Session 2)
Bringing estimands to life through a real case study. Members of the estimands Implementation Working Group (EIWG) will describe the background and study objectives, intercurrent events of interest and chosen estimands in the PIONEER study.
Our annual PSI Medical Statistics Careers Event, will be held online using the Career Fair Plus app on Wednesday 3rd March 2021. The event will include a live online panel discussion and a virtual exhibition session.
Discover your extraordinary potential by working as a Covance AD, Biostatistics / Senior Principal Biostatistician. You will consult in the design of complex and innovative studies & clinical trial programs as well as Leading DMC/DSMB processes.
By joining our company, in this role you will apply your skills and experience in support of developing scientifically based arguments aiming to provide fair accessibility to our company’s drugs and vaccines making a real difference in patient’s lives.
Senior Principal / Principal Biostatistician (Oncology) – FSP
Join our team as a Covance FSP Senior Principal or Principal Biostatistician. You will be assigned to one Sponsor working on Phase I and II oncology studies. Previous Lead experience essential. Office or home-based anywhere in Europe or South Africa.